Supernus Pharmaceuticals, Inc. · 1 month ago
Executive Director, Development Asset Leadership
Supernus Pharmaceuticals is an award-winning biopharmaceutical company with more than 30 years of experience in developing and commercializing products that treat central nervous system (CNS) diseases. The Executive Director, Development Asset Leadership, is responsible for leading the oversight and execution of the company’s pharmaceutical development programs from early discoveries through commercialization.
BiotechnologyHealth CarePharmaceutical
Responsibilities
Lead the development, implementation, and continuous refinement of asset development strategies aligned with Target Product Profiles (TPP)
Define and own the overall clinical strategy, clinical development plans, and Integrated Development Plans
Holds cross functional team members accountable for establishing and achieving ambitious yet attainable annual objectives
Work with Portfolio and Program Management to establish KPIs for each development program
Drive, facilitate, and oversee the development and execution of clinical development plans, protocol generation, study design, and endpoints to ensure that programs meet their intended value in alignment with TPP
Partner with portfolio and program management to lead and inspire cross functional teams of preclinical, CMC, medical writers, clinical development, clinical operations, biostatistics, and regulatory to execute on the development strategy across programs
Partner with Executive Leadership to align portfolio decisions with company strategy, scientific priorities, and market needs
Oversee portfolio governance processes, including prioritization frameworks, resource allocation, and scenario planning
Develop and utilize KPIs, dashboards, and performance metrics to track portfolio progress, risk, and decision making across programs
Provide executive leadership for all cross-functional development programs (preclinical, clinical, regulatory, CMC, commercial)
Ensure programs are delivered on time, within scope and budget, and in alignment with quality and compliance standards
Build, lead, and mentor high-performing Portfolio & Program Management teams and hold teams accountable for deliverables
Foster strong working relationships across R&D, Regulatory, Commercial, Finance, and other departments
Serves as the key liaison to the Executive Committee for program/portfolio status updates, investment cases, and critical risks
Lead program review committees and other governance bodies to support decision making
Support business development, partnership evaluations, and due diligence processes from a portfolio perspective
Oversees the Internal Controls in Areas of Responsibilities
Other responsibilities and projects assigned
Qualification
Required
Bachelor's degree required and a minimum of 14 years of relevant experience in the pharmaceutical or biotechnology industry, including at least 10 years in R&D program/portfolio management leadership roles
Demonstrated success leading complex, cross-functional drug development programs across multiple phases (e.g., IND through NDA/BLA submission and approval)
Ability to understand large, complex budgets and accurately track expenditures against them
Strong presentation skills with the ability to influence at all levels of the organization
Ability to work independently and as part of a team and maintain high ethical standards of integrity and quality
Ability to have an innovative and dynamic approach to work
A self-starter able to work independently but comfortable working in a team environment
Ability to consistently exhibit Supernus Values in interactions with employees at all levels of the organization, vendors, customers and others
Capable of performing other duties as assigned by Management
Authorized to legally work in the United States without visa sponsorship
Preferred
Advanced degree in life sciences (PhD, PharmD, MD) strongly preferred, master's degree is a plus
Experience in CNS (Psych and Neuro), and/or Orphan/Rare Diseases preferred
Experience in both pharma and high-growth biotech environments preferred
Benefits
Employee stock purchase programs
Performance-based bonus programs
Company
Supernus Pharmaceuticals, Inc.
We are a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases.
Funding
Current Stage
Public CompanyTotal Funding
$689.5MKey Investors
UBSNew Enterprise Associates
2023-02-14Post Ipo Debt· $150M
2018-03-13Post Ipo Debt· $350M
2013-04-24Post Ipo Debt· $90M
Recent News
2025-12-08
Company data provided by crunchbase